Detalles de la búsqueda
1.
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer.
Breast Cancer Res Treat
; 188(1): 149-163, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818652
2.
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond.
Lung Cancer
; 156: 147-150, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965281
Resultados
1 -
2
de 2
1
Próxima >
>>